mergers-and-acquisitions News
Cenovus Revamps MEG Energy Bid, Securing Key Rival's Support
Sweetened offer and strategic asset sale to Strathcona Resources pave the way for $8.5 billion oil sands merger, breaking previous deadlock.
Novo Nordisk's $5.2B Akero Deal Fuels Biotech M&A Speculation
Acquisition for promising liver disease drug signals big pharma's growing appetite for mid-cap assets, sparking investor optimism in the MASH treatment space.
Novartis’s M&A Hunt Puts RNA Leaders Like Avidity in the Spotlight
With a multi-billion-dollar war chest, the Swiss drugmaker is under pressure to acquire innovative platforms, and Avidity's targeted RNA technology presents a compelling strategic fit.
Novartis to Buy Avidity Biosciences in $12B Deal for RNA Drugs
The all-cash offer of $72 per share represents a 46% premium, bolstering the Swiss drugmaker's pipeline with promising treatments for muscular dystrophy.
Plymouth REIT to Go Private in $2.1B Deal with Makarora, Ares
Shareholders to receive $22.00 per share in an all-cash transaction, representing a nearly 50% premium over the REIT's unaffected stock price.
Eli Lilly to Acquire Adverum Bio in Deal Valued Up to $12.47/Share
The acquisition bolsters Lilly's gene therapy pipeline with Adverum's late-stage treatment for wet age-related macular degeneration, Ixo-vec.
Nicolet Bankshares to Acquire MidWestOne in $864M All-Stock Deal
The merger creates a $15 billion regional banking powerhouse in the Upper Midwest, announced alongside strong Q3 earnings from both banks.
RaceTrac to Acquire Potbelly for $566 Million in Food-Service Push
The all-cash deal at $17.12 per share marks the convenience store giant's aggressive expansion into the fast-casual restaurant sector, taking the sandwich chain private.